Logan Capital Management Maintains Position in Celgene Com (CELG); Sterneck Capital Management Has Boosted Intel (INTC) Position by $1.17 Million

Celgene Corporation (NASDAQ:CELG) Logo

Sterneck Capital Management Llc increased its stake in Intel Corp (INTC) by 4155.33% based on its latest 2018Q3 regulatory filing with the SEC. Sterneck Capital Management Llc bought 24,932 shares as the company’s stock rose 1.97% while stock markets declined. The institutional investor held 25,532 shares of the semiconductors company at the end of 2018Q3, valued at $1.21 million, up from 600 at the end of the previous reported quarter. Sterneck Capital Management Llc who had been investing in Intel Corp for a number of months, seems to be bullish on the $226.96B market cap company. The stock increased 0.92% or $0.46 during the last trading session, reaching $50.47. About 17.71M shares traded. Intel Corporation (NASDAQ:INTC) has risen 9.59% since February 14, 2018 and is uptrending. It has outperformed by 9.59% the S&P500. Some Historical INTC News: 16/04/2018 – Tech Report: Rumor: Intel partner docs add to eight-core Coffee Lake CPU chatter; 13/03/2018 – Senate Intel chairman Burr says expects to back Haspel to head CIA; 11/04/2018 – DOJ’s Rosenstein shows House Intel Committee the document that sparked FBI’s Russia probe; 15/03/2018 – Asetek: Asetek Announces Ongoing Collaboration with Intel on Liquid Cooling for Servers and Datacenters; 07/03/2018 – DEADLINE ALERT – Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Intel Corporation (INTC) & Lead; 09/03/2018 – Intel, Facing Threat, Considers Deals That Could Include Bid for Broadcom — 4th Update; 26/04/2018 – INTEL CORP – QTRLY DATA CENTER GROUP REVENUE $5.2 BILLION, UP 24%; 08/05/2018 – Techmeme: Source: Qualcomm is exploring whether to shutter or sell its server chip business, a sector that Intel dominates (…; 29/03/2018 – Schneider Electric Receives Supplier Achievement Award from Strategic Partner, Intel; 20/03/2018 – Global Hyperscale Data Centers Markets Report 2018: Major Players are Brocade Communications Systems, DataCore Software, Hitachi Data Systems, Intel, Neustar and Pure Storage – ResearchAndMarkets.com

Logan Capital Management Inc increased its stake in Celgene Corp Com (CELG) by 4.06% based on its latest 2018Q3 regulatory filing with the SEC. Logan Capital Management Inc bought 3,558 shares as the company’s stock declined 22.96% with the market. The institutional investor held 91,282 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $8.17M, up from 87,724 at the end of the previous reported quarter. Logan Capital Management Inc who had been investing in Celgene Corp Com for a number of months, seems to be bullish on the $62.84 billion market cap company. The stock increased 0.74% or $0.66 during the last trading session, reaching $89.74. About 8.65 million shares traded. Celgene Corporation (NASDAQ:CELG) has declined 33.15% since February 14, 2018 and is downtrending. It has underperformed by 33.15% the S&P500. Some Historical CELG News: 19/03/2018 – Denali Therapeutics 4Q Loss/Shr 74c; 28/03/2018 – ABIDE SAYS CELGENE’S OPTION TO BUY CO. HAVE BEEN TERMINATED; 29/05/2018 – DEADLINE TODAY: The Klein Law Firm Reminds Investors of a Class Action Commenced on Behalf of Celgene Corporation Shareholders; 09/04/2018 – STAT Plus: With positive Keytruda data, Merck scrambles the market for lung cancer immunotherapies; 09/04/2018 – KEYTRUDA® (PEMBROLIZUMAB) MONOTHERAPY MET PRIMARY ENDPOINT IN; 16/04/2018 – Biothera Pharmaceuticals Presents Translational Data from Ongoing Clinical Trials Showing lmprime PGG in Combination with Merck’s KEYTRUDA® (pembrolizumab) Drives lnnate and Adaptive Immune Responses in Tumors; 28/03/2018 – BLUEBIRD BIO & CELGENE WILL SHARE 50% OF U.S. COSTS & PROFITS; 17/05/2018 – Celgene Presenting at Conference Jun 1; 04/05/2018 – CELGENE CORP SEES 2018 GAAP DILUTED EPS ABOUT $6.31 WITH DILUTION FROM JUNO; 15/05/2018 – STAT Plus: Azar calls out a Celgene drug for price hikes that are hurting Medicare

Among 35 analysts covering Celgene Corporation (NASDAQ:CELG), 22 have Buy rating, 0 Sell and 13 Hold. Therefore 63% are positive. Celgene Corporation had 161 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Celgene Corporation (NASDAQ:CELG) earned “Buy” rating by SunTrust on Monday, January 8. The firm has “Buy” rating given on Friday, July 15 by Stifel Nicolaus. The stock of Celgene Corporation (NASDAQ:CELG) has “Buy” rating given on Thursday, September 29 by Citigroup. The stock has “Equal-Weight” rating by Morgan Stanley on Monday, May 7. The firm has “Hold” rating given on Thursday, May 31 by Cantor Fitzgerald. The rating was downgraded by Standpoint Research to “Hold” on Wednesday, November 9. BMO Capital Markets maintained it with “Buy” rating and $147.0 target in Monday, January 8 report. On Wednesday, June 1 the stock rating was downgraded by BTIG Research to “Neutral”. The rating was maintained by UBS on Friday, November 6 with “Buy”. The stock of Celgene Corporation (NASDAQ:CELG) earned “Hold” rating by Bank of America on Friday, January 5.

More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: Nasdaq.com which released: “Peek Under The Hood: IUSG Has 11% Upside – Nasdaq” on January 31, 2019, also Investorplace.com with their article: “Celgene vs. Gilead Stock: What’s the Better Biotech Buy? – Investorplace.com” published on February 13, 2019, Fool.com published: “1 Chart That Shows Why Celgene Has Been Bought Out and Gilead Hasn’t (Yet) – The Motley Fool” on January 17, 2019. More interesting news about Celgene Corporation (NASDAQ:CELG) were released by: Nasdaq.com and their article: “Are These The Next Biotech Buyout Targets? – Nasdaq” published on January 22, 2019 as well as Seekingalpha.com‘s news article titled: “Celgene Corporation 2018 Q4 – Results – Earnings Call Slides – Celgene Corporation (NASDAQ:CELG) – Seeking Alpha” with publication date: January 31, 2019.

Investors sentiment increased to 0.93 in 2018 Q3. Its up 0.22, from 0.71 in 2018Q2. It increased, as 58 investors sold CELG shares while 418 reduced holdings. 113 funds opened positions while 332 raised stakes. 468.90 million shares or 1.67% less from 476.86 million shares in 2018Q2 were reported. 120,332 were reported by First Manhattan Co. Aviva Public Llc reported 468,941 shares. Point72 Asset Management Lp invested in 0.25% or 670,181 shares. Lederer & Assoc Investment Counsel Ca reported 17,910 shares. Oak Associate Limited Oh holds 0.14% or 25,600 shares. Rathbone Brothers Pcl reported 11,305 shares or 0.03% of all its holdings. Moreover, Prudential Inc has 0.35% invested in Celgene Corporation (NASDAQ:CELG) for 2.68M shares. Dekabank Deutsche Girozentrale accumulated 0.39% or 693,419 shares. 455,040 were reported by Aperio Ltd. British Columbia Invest has 250,092 shares for 0.24% of their portfolio. Fdx Advsr has invested 0.02% in Celgene Corporation (NASDAQ:CELG). Lincoln National, Pennsylvania-based fund reported 8,632 shares. Employees Retirement Systems Of Ohio invested 0.21% in Celgene Corporation (NASDAQ:CELG). 283,072 were accumulated by Marshall Wace Ltd Liability Partnership. Intrust Retail Bank Na invested in 5,758 shares or 0.13% of the stock.

Logan Capital Management Inc, which manages about $2.06 billion and $1.53 billion US Long portfolio, decreased its stake in Alphabet Inc. Class C by 256 shares to 10,743 shares, valued at $12.82M in 2018Q3, according to the filing. It also reduced its holding in Starbucks Corp Com (NASDAQ:SBUX) by 7,121 shares in the quarter, leaving it with 347,865 shares, and cut its stake in Amerisourcebergen Com (NYSE:ABC).

Since February 7, 2019, it had 0 buys, and 1 sale for $2.05 million activity.

Since August 20, 2018, it had 2 insider purchases, and 10 insider sales for $893,913 activity. On Monday, January 28 the insider Shenoy Navin sold $33,256. $247,155 worth of Intel Corporation (NASDAQ:INTC) was bought by SWAN ROBERT HOLMES on Thursday, November 29. 2,235 Intel Corporation (NASDAQ:INTC) shares with value of $102,050 were sold by Rodgers Steven Ralph.

Among 57 analysts covering Intel Corporation (NASDAQ:INTC), 32 have Buy rating, 7 Sell and 18 Hold. Therefore 56% are positive. Intel Corporation had 304 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Sector Perform” rating by RBC Capital Markets given on Friday, November 20. The firm has “Buy” rating by Loop Capital given on Tuesday, December 13. Sterne Agee CRT initiated the stock with “Buy” rating in Wednesday, September 9 report. The firm has “Sell” rating by Jefferies given on Friday, July 28. The rating was maintained by Morgan Stanley on Friday, January 26 with “Equal-Weight”. The rating was maintained by JP Morgan on Wednesday, April 20 with “Overweight”. Jefferies maintained the stock with “Sell” rating in Tuesday, October 3 report. UBS downgraded the shares of INTC in report on Tuesday, January 5 to “Neutral” rating. The firm earned “Outperform” rating on Friday, January 15 by Wedbush. The rating was maintained by Citigroup on Thursday, July 21 with “Neutral”.

More notable recent Intel Corporation (NASDAQ:INTC) news were published by: Bizjournals.com which released: “Intel outlines expansion plans with Hillsboro neighbors – Portland Business Journal” on February 05, 2019, also Nasdaq.com with their article: “Semiconductor Earnings Scorecard: INTC, TXN, XLNX, LRCX, ASML – Nasdaq” published on February 01, 2019, Nasdaq.com published: “INTC’s Strong Dividend History Helps it Reach ‘Top Dividend Stock of the Dow’ – Nasdaq” on February 04, 2019. More interesting news about Intel Corporation (NASDAQ:INTC) were released by: Nasdaq.com and their article: “Top Buys by Top Brass: Interim CEO Swan’s $493.1K Bet on INTC – Nasdaq” published on January 31, 2019 as well as Nasdaq.com‘s news article titled: “Here’s When Intel’s Processor Shortage Could Be Over – Nasdaq” with publication date: January 21, 2019.

Sterneck Capital Management Llc, which manages about $314.88 million and $138.82 million US Long portfolio, decreased its stake in Coca Cola Co (NYSE:KO) by 35,426 shares to 8,812 shares, valued at $407,000 in 2018Q3, according to the filing. It also reduced its holding in Gilead Sciences Inc (NASDAQ:GILD) by 4,498 shares in the quarter, leaving it with 42,047 shares, and cut its stake in International Business Machs (NYSE:IBM).

Investors sentiment increased to 0.85 in 2018 Q3. Its up 0.04, from 0.81 in 2018Q2. It is positive, as 62 investors sold INTC shares while 728 reduced holdings. 113 funds opened positions while 557 raised stakes. 2.86 billion shares or 2.41% less from 2.93 billion shares in 2018Q2 were reported. Cambridge Tru holds 0.19% or 71,255 shares. Neville Rodie And Shaw accumulated 1.25% or 267,474 shares. Cullen Capital Ltd Com has invested 1.45% in Intel Corporation (NASDAQ:INTC). Valicenti Advisory reported 108,247 shares. Callahan Advsr Limited Liability Company holds 278,490 shares or 2.44% of its portfolio. Gould Asset Mngmt Limited Liability Corp Ca has invested 0.16% of its portfolio in Intel Corporation (NASDAQ:INTC). Northstar Asset Ltd Liability owns 0.56% invested in Intel Corporation (NASDAQ:INTC) for 30,353 shares. Compton Capital Ri invested in 53,737 shares or 1% of the stock. Rbo & Limited Liability Corp has invested 0.05% in Intel Corporation (NASDAQ:INTC). Moreover, Acr Alpine Cap Research Limited Liability Com has 0.01% invested in Intel Corporation (NASDAQ:INTC). Glob Invsts holds 1.48% in Intel Corporation (NASDAQ:INTC) or 107.84 million shares. 6,820 were accumulated by Cognios Cap Ltd. 142,958 were reported by North American Corporation. Violich Capital Management holds 20,946 shares or 0.23% of its portfolio. Segment Wealth invested in 0.05% or 4,734 shares.

Intel Corporation (NASDAQ:INTC) Institutional Positions Chart